Cargando...

Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect

INTRODUCTION: Osteoporosis is a disease characterized by low bone mineral density and poor bone quality resulting in reduced bone strength and increased risk of fracture. Oral bisphosphonates, first-line therapy for most patients with osteoporosis, are associated with suboptimal adherence to therapy...

Descrición completa

Gardado en:
Detalles Bibliográficos
Autor Principal: Lewiecki, E Michael
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2010
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2899787/
https://ncbi.nlm.nih.gov/pubmed/20694061
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!